ARCHIVES

DCT Board Approves Concepts Of Eight New Biological Response Modifiers Program

This article is from The Cancer Letter archive.

Vol. 07 No. 27 | July 3, 1981

Download PDF Visit The Full Archive

Related Articles

UICC Grant Programs Available To Support International Activities

April 16, 1976

FDA Approves Lapatinib For Advanced Breast Cancer

March 30, 2007

Specific Pathology Pattern Can Predict Recurrence

August 30, 2013

Cobimetinib-Zelboraf Therapy Increases OS In BRAF V600 Mutation-Positive Disease

October 31, 2014

House Committee Allocates NCI $1.347 Billion, $189 Million Over President’s Request For 1987

August 1, 1986

BCDDP “Major Accomplishment” Described By ACS’ Holleb

July 21, 1978